콘텐츠로 건너뛰기
주식/증권 📈 긍정적

NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up

요약

NeuroPace's Q2 revenues rise 17.1% as RNS demand strengthens, while a narrower loss and higher 2026 outlook highlight continued momentum.